Published in
Taylor and Francis Group, Expert Opinion on Therapeutic Targets, 4(26), p. 333-345, 2022
DOI: 10.1080/14728222.2022.2067040
Links
Tools
Tenosynovial giant cell tumors (TGCT): molecular biology, drug targets and non-surgical pharmacological approaches
Journal article published in 2022 by
Geert Spierenburg 
,
Lizz van der Heijden ,
Kirsten van Langevelde ,
Karoly Szuhai ,
Judith V. G. M. Bovée ,
Michiel A. J. van de Sande ,
Hans Gelderblom
,
Lizz van der Heijden ,
Kirsten van Langevelde ,
Karoly Szuhai ,
Judith V. G. M. Bovée ,
Michiel A. J. van de Sande ,
Hans Gelderblom
Distributing this paper is prohibited by the publisher
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 